Oramed Pharmaceuticals. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com) strategic partner, Hefei Tianhui Biotechnology (HTIT), has completed its Phase III trials of
NANO-X IMAGING LTD ("Nanox" Nasdaq: NNOX), an innovative medical imaging technology company, announced that its deep-learning medical imaging analytics subsidiary,
With 2M$ gained through pre-seed funding, Itay&Beyond has initiated the recruitment of 200 low-functioning individuals with Autistic Spectrum Disorder (ASD)